/
ADN
$0.92-$1.79 (-66.11%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.90 – $6.18
0% from low
Price (6 mo)
Loading chart…
Change$-288.28
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Revenue | $373.7K | $620.2K | $882.7K | $7.1M | $7.8M | $1.5M | $3.3M |
| Cost of revenue | $200.5K | $397.4K | $513.8K | $5.4M | $8.6M | $7.0M | $1.5M |
| Gross profit | $173.2K | $222.8K | $368.8K | $1.7M | −$744.0K | −$5.4M | $1.8M |
| Gross margin | 46.4% | 35.9% | 41.8% | 23.5% | -9.5% | -353.4% | 54.6% |
| R&D | $100.0K | $124.7K | $102.5K | $3.5M | $9.8M | $7.6M | $3.2M |
| Operating income | −$351.0K | −$173.7K | −$3.1M | −$44.1M | −$85.4M | −$50.7M | −$18.4M |
| EBITDA | −$329.2K | −$157.2K | −$3.1M | −$34.1M | −$44.6M | −$38.4M | −$27.9M |
| Net income | −$565.4K | −$358.3K | −$3.1M | −$20.5M | −$74.3M | −$71.4M | −$41.0M |
| Net margin | -151.3% | -57.8% | -353.6% | -290.3% | -948.5% | -4648.2% | -1251.3% |
| EPS (diluted) | 0.00 | -12.10 | -4.56 | -13.50 | -43.28 | -26.55 | -11.46 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $395M | $39.39 | $39.39–$39.39 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
Held by traders on TradeandTell
No one on the platform currently holds ADN.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in ADN as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2024-05-14 | 1-for-30reverse |
Recent trades on TradeandTell
No one on the platform has traded ADN yet.
